Decoding resistance to immune checkpoint inhibitors in non-small cell lung cancer: a comprehensive analysis of plasma proteomics and therapeutic implications
Background Immune checkpoint inhibitors (ICIs) have shown substantial benefit for patients with advanced non-small cell lung cancer (NSCLC). However, resistance to ICIs remains a major clinical challenge. Here, we perform a comprehensive bioinformatic analysis of plasma proteomic profiles to explore...
Saved in:
| Main Authors: | David P Carbone, Igor Puzanov, Ronan J Kelly, Yuval Shaked, Michal Harel, Coren Lahav, Eyal Jacob, Nili Dahan, David R Gandara, Yehonatan Elon, Adam P Dicker, Raya Leibowitz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/5/e011427.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Time‐series transcriptomics and proteomics reveal alternative modes to decode p53 oscillations
by: Alba Jiménez, et al.
Published: (2022-03-01) -
Authors response to “Letter to the Editor”: “Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types”
by: David R Gandara, et al.
Published: (2025-07-01) -
Urine proteomics defines an immune checkpoint-associated nephritis signature
by: Cassian Yee, et al.
Published: (2025-01-01) -
Single Cell‐Pair Proteomics for Decoding Immune‐Cancer Cell Interactions
by: Qin‐Qin Xu, et al.
Published: (2025-03-01) -
Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma
by: Ruth Halaban, et al.
Published: (2024-03-01)